Trupanion (NASDAQ:TRUP) Issues Earnings Results, Beats Expectations By $0.05 EPS

Trupanion (NASDAQ:TRUP) posted its quarterly earnings results on Thursday. The financial services provider reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.05, FiscalAI reports. Trupanion had a return on equity of 5.96% and a net margin of 1.53%. The business had revenue of $405.59 million for the quarter, compared to analysts’ expectations of $402.53 million. During the same quarter in the prior year, the business earned $0.13 EPS.

Here are the key takeaways from Trupanion’s conference call:

• Trupanion reported record third-quarter adjusted operating income of $47 million, up 15% year over year, on revenue of $405.6 million, up 11%. Free cash flow also reached a record $28.5 million, and the company reported its sixth consecutive quarter of positive net income.
• Growth and customer metrics improved: net new pets exceeded 20,500, up more than 28% year over year, while average monthly retention rose for the seventh consecutive quarter to 98.38%. Management attributed stronger conversion and lower acquisition cost per pet in part to expanded plan options and digital enrollment improvements.
• The company raised the midpoint of its full-year adjusted operating income outlook to $180.5 million, implying about 19% year-over-year growth, and expects fourth-quarter adjusted operating income of $48 million to $51 million. Full-year subscription revenue is now expected to grow about 14% at the midpoint.
• Management expects veterinary cost inflation to remain in the double digits into 2027, requiring continued pricing adjustments. It said average member increases may ease as pricing catches up with costs, but affordability remains an important consideration.
• Trupanion repurchased about $25 million of shares in the quarter and repaid $15 million of borrowings after quarter-end, while continuing to fund growth initiatives. Its Landspath pet-food trials are underway, but management expects limited revenue from the initiative over the next 18 months.

Trupanion Stock Performance

TRUP traded up $1.05 during trading on Thursday, hitting $34.72. The stock had a trading volume of 733,923 shares, compared to its average volume of 380,780. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The company has a 50 day moving average price of $27.00 and a 200-day moving average price of $26.66. Trupanion has a one year low of $21.16 and a one year high of $46.98. The firm has a market cap of $1.52 billion, a price-to-earnings ratio of 63.54, a P/E/G ratio of 2.01 and a beta of 1.27.

Insiders Place Their Bets

In other news, CEO Margaret Tooth sold 1,000 shares of the business’s stock in a transaction dated Friday, October 9th. The shares were sold at an average price of $25.84, for a total value of $25,840.00. Following the completion of the sale, the chief executive officer owned 184,952 shares of the company’s stock, valued at approximately $4,779,159.68. The trade was a 0.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO John R. Gallagher sold 3,604 shares of the company’s stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $29.70, for a total transaction of $107,038.80. Following the completion of the transaction, the chief operating officer owned 33,742 shares in the company, valued at $1,002,137.40. This trade represents a 9.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 14,046 shares of company stock worth $407,743 in the last 90 days. Company insiders own 5.58% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Weiss Ratings upgraded shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, September 29th. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and cut their target price for the stock from $45.00 to $32.00 in a research note on Wednesday, August 26th. Atlantic Securities set a $42.00 target price on shares of Trupanion in a research note on Wednesday, July 15th. Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Finally, Stifel Nicolaus upped their price target on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research note on Thursday, August 20th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Trupanion currently has an average rating of “Hold” and a consensus target price of $38.40.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.

The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.